| Description |
1 online resource |
| Series |
SAGE Business Cases |
|
SAGE Business Cases
|
| Summary |
Neuralink Corp (Neuralink) is a San Francisco-based neurotechnology company founded and led by Elon Musk. Musk invested in a brain-machine (computer) interface (BCI) ostensibly to combat potentially dangerous artificial intelligence applications. BCI is a computer-based system that receives brain signals and translates them into commands. These commands are then transmitted to the output device that carries the desired action. Musk first wanted to cure brain-related diseases, followed by enhancing the cognitive ability of humans. However, he faced several challenges. Implementing a BCI involved invasive surgery, and experts believed that the average person might not be willing to undergo surgery to enhance cognitive abilities such as faster typing on a keyboard. Also, non-invasive technologies were available, and competition was increasing. Some experts believed that BCI was closer to science fiction, with limited market demand. Some companies were also considering skipping the U.S. Food and Drug Administration approval of neurotechnology by marketing it as a wellness product. Should Musk pursue a non-invasive or an invasive BCI technology? Should companies market neurotechnology as a wellness product? Will Musk find success with invasive BCI technology? |
| Notes |
Description based on XML content |
| Subject |
Product management -- Case studies
|
|
Human body and technology -- Case studies
|
|
Human body and technology
|
|
Product management
|
| Genre/Form |
Case studies
|
| Form |
Electronic book
|
| Author |
Bhattacharya, Saurabh, author
|
| ISBN |
9781529611762 |
|
1529611768 |
|
